Publications:32

Chitra Upadhyay, PhD
About Me
My research focusses on understanding the antiviral functions of antibodies against the variable loops of HIV-1 and their mechanism of protection. The V2 and V3 loops on HIV-1 envelope are valuable targets for immunogen design but are conformationally masked and poorly accessible by the neutralizing antibodies. This masking of the neutralizing epitopes present in the V2 and V3 regions of HIV-1 is regulated by distinct mechanisms. Neutralization of relatively resistant HIV-1 isolates is achievable under modified conditions when the antibodies are allowed to interact with the virus for a prolonged period of time. Additionally, I am also interested in the extraordinary functional and antigenic heterogeneity of the HIV-1 envelope protein specifically its glycosylation, which is a vital part of the HIV-1 architecture. My study focuses on the role of diverse compositions of N-linked-glycans on HIV-1 Env, such as high mannose-type and complex-type glycans, on viral infectivity, regulation of spike conformation, immune evasion, virus transmission.
My prior research was dedicated at developing replication-competent viral vectors for therapeutic use and highly sensitive diagnostic assay for avian influenza, infectious bursal disease and dengue viruses.
My prior research was dedicated at developing replication-competent viral vectors for therapeutic use and highly sensitive diagnostic assay for avian influenza, infectious bursal disease and dengue viruses.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
Publications
Selected Publications
- Correction: Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1 (Scientific Reports, (2025), 15, 1, (41988), 10.1038/s41598-025-26149-z). Jéromine Klingler, Priyanka Gadam Rao, Juan C. Bandres, Ismael Pena, Katherine Bolanos Roldan, Gagandeep Singh, Brian Monahan, Charles Gleason, Yuexing Chen, Stefan Slamanig, Weina Sun, Chitra Upadhyay, Catarina E. Hioe. Scientific Reports
- Virus particle-based antibody-dependent cellular phagocytosis assay for HIV. Chitra Upadhyay, Priyanka Gadam Rao. Frontiers in Immunology
- Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1. Jéromine Klingler, Priyanka Gadam Rao, Juan C. Bandres, Ismael Pena, Katherine Bolanos Roldan, Gagandeep Singh, Brian Monahan, Charles Gleason, Yuexing Chen, Stefan Slamanig, Weina Sun, Chitra Upadhyay, Catarina E. Hioe. Scientific Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Upadhyay has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.